![\"\"](\"https:\/\/by-tv.co.uk\/wp-content\/uploads\/2025\/12\/Gemini_Generated_Image_g5yqr1g5yqr1g5yq.jpg\")
<\/a><\/div>\n100 milyon doz a\u015f\u0131 almay\u0131 bekleyen Br\u00fcksel’e bunun ancak d\u00f6rtte birine yak\u0131n bir miktar\u0131 teklif eden \u015firket, gerek\u00e7e olarak Bel\u00e7ika’daki \u00fcretim tesislerindeki sorunu g\u00f6sterdi. <\/p>\n
Ancak Avrupal\u0131 \u200b\u200byetkililer, merkezi \u0130ngiltere’de bulunan AstraZeneca’n\u0131n, AB \u00fclkeleri i\u00e7in ayr\u0131lan a\u015f\u0131lar\u0131 \u0130ngiltere’ye verdi\u011fini ima etti. <\/p>\n
– AB \u015fa\u015fk\u0131nl\u0131\u011fa u\u011frad\u0131 <\/p>\n
Pfizer ve Moderna a\u015f\u0131lar\u0131na k\u0131yasla daha d\u00fc\u015f\u00fck fiyat\u0131 ve daha kolay depolama gereksinimleri dolay\u0131s\u0131yla AstraZeneca a\u015f\u0131s\u0131na b\u00fcy\u00fck umut ba\u011flayan AB, bu a\u00e7\u0131klama kar\u015f\u0131s\u0131nda \u015fa\u015fk\u0131nl\u0131\u011fa u\u011frad\u0131.<\/p>\n
AB Komisyonu, ge\u00e7en hafta \u00fcye \u00fclkelerindeki yeti\u015fkin n\u00fcfusun y\u00fczde 70’inin 1 Haziran’a kadar a\u015f\u0131lanmas\u0131 hedefi koymu\u015ftu. Ancak a\u015f\u0131 teslimatlar\u0131nda ya\u015fanacak gecikmeler sonucunda hedefin yakalanamama ihtimali y\u00fcksek g\u00f6r\u00fcn\u00fcyor.<\/p>\n
– “S\u00f6z vermedik”<\/p>\n
AstraZeneca’n\u0131n CEO’su Pascal Soriot, \u0130talyan La Repubblica gazetesine verdi\u011fi deme\u00e7te, \u015firketinin a\u015f\u0131y\u0131 AB’ye \u0130ngiltere’ye oldu\u011fu kadar h\u0131zl\u0131 teslim etme s\u00f6z\u00fc vermedi\u011fini belirtti.<\/p>\n
Soriot, “Avrupa, s\u00f6zle\u015fmeyi (\u0130ngiltere’den) 3 ay sonra imzalam\u0131\u015f olmas\u0131na ra\u011fmen, \u0130ngiltere ile ayn\u0131 anda tedarik etmek istiyor.” dedi.<\/p>\n
Ellerinden gelenin en iyisini yapacaklar\u0131n\u0131 ifade eden Soriot, ancak taahh\u00fctte bulunamayacaklar\u0131n\u0131 vurgulad\u0131. <\/p>\n
Bu geli\u015fme ve a\u00e7\u0131klama, AB’yi daha da k\u0131zd\u0131rd\u0131. AB, AstraZeneca yetkilileriyle toplant\u0131 d\u00fczenlemek istedi ancak 27 Ocak’taki toplant\u0131ya AstraZeneca kat\u0131lmad\u0131.<\/p>\n
Bir AB yetkilisi, \u015firketin toplant\u0131ya kat\u0131lmak yerine yaz\u0131l\u0131 olarak AB Komisyonuna bildirim yapaca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131.<\/p>\n
– AB, \u0130ngiltere’ye Pfizer a\u015f\u0131s\u0131n\u0131n ihracat\u0131n\u0131 yasaklayabilir <\/p>\n
Bu geli\u015fmeler aras\u0131nda Avrupa bas\u0131n\u0131, Birli\u011fin de BioNTech ve Pfizer a\u015f\u0131lar\u0131n\u0131n \u0130ngiltere’ye g\u00f6nderilmesini engellemekle tehdit etti\u011fini \u00f6ne s\u00fcrd\u00fc.<\/p>\n
Bu y\u00f6nde karar al\u0131naca\u011f\u0131na dair resmi bir a\u00e7\u0131klama olmasa da bu durum, \u0130ngiliz Muhafazakar Parti \u00fcyelerini k\u0131zd\u0131rd\u0131. <\/p>\n
Brexit’in hemen ard\u0131ndan ya\u015fanan bu geli\u015fme kar\u015f\u0131s\u0131nda AB kar\u015f\u0131tlar\u0131, Birlikten ayr\u0131lmakta hakl\u0131 olduklar\u0131n\u0131 s\u00f6ylemeye ba\u015flad\u0131. <\/p>\n
Muhafazakar Parti’den David Jones, \u0130ngiliz bas\u0131n\u0131na verdi\u011fi deme\u00e7te, olas\u0131 ihracat yasa\u011f\u0131 tehdidinin “\u015fantaja \u00e7ok benzedi\u011fini ve AB’den ayr\u0131lmakta neden hakl\u0131 olduklar\u0131n\u0131 g\u00f6sterdi\u011fini” kaydetti. <\/p>\n
– “Ahlaki sorumluluklar\u0131 var”<\/p>\n
AB cephesi ise b\u00f6yle bir ihracat yasa\u011f\u0131 karar\u0131 olmad\u0131\u011f\u0131n\u0131 belirtti. <\/p>\n
AB Komisyonunun Sa\u011fl\u0131ktan Sorumlu \u00dcyesi Stella Kyriakides, 27 Ocak’ta d\u00fczenledi\u011fi bas\u0131n toplant\u0131s\u0131nda, “\u0130la\u00e7 \u015firketleri ve a\u015f\u0131 geli\u015ftiricilerinin uymalar\u0131 gereken ahlaki, toplumsal ve s\u00f6zle\u015fmeye ba\u011fl\u0131 sorumluluklar\u0131 var.” diyerek, AstraZeneca’y\u0131 su\u00e7lam\u0131\u015ft\u0131. <\/p>\n
S\u00f6zle\u015fmedeki bir maddede, “\u015firketin teslimatlar i\u00e7in en y\u00fcksek \u00e7abay\u0131” g\u00f6sterece\u011fine y\u00f6nelik maddeyi gerek\u00e7e g\u00f6stermesine de\u011finen Kyriakides, AstraZeneca’n\u0131n “en y\u00fcksek \u00e7abay\u0131” g\u00f6sterdi\u011fini ve tedarik y\u00fck\u00fcml\u00fcl\u00fcklerine uymamas\u0131n\u0131 kabul edemeyeceklerini vurgulad\u0131.<\/p>\n
Kyriakides, s\u00f6zle\u015fme gere\u011fi ikisi AB \u00fclkelerinde ikisi \u0130ngiltere’de bulunan 4 fabrikada \u00fcretilen a\u015f\u0131lara eri\u015fim haklar\u0131 bulundu\u011funa i\u015faret etti.<\/p>\n
– “Mesele, AB’deki ve AstraZeneca’daki dostlar\u0131m\u0131z aras\u0131nda”<\/p>\n
Konu, \u0130ngiltere Ba\u015fbakan\u0131 Boris Johnson’a da soruldu. Ancak Johnson, muhabirlerin t\u00fcm \u0131srarlar\u0131na ra\u011fmen tart\u0131\u015fmaya girmeyi reddetti.<\/p>\n
AB’nin olas\u0131 bir ihracat yasa\u011f\u0131n\u0131 dikkate al\u0131p almayaca\u011f\u0131 konusundaki sorular\u0131 da yan\u0131tlamaktan ka\u00e7\u0131nan Ba\u015fbakan, “Oxford-AstraZeneca a\u015f\u0131s\u0131, \u00fclkemiz ve d\u00fcnya i\u00e7in a\u00e7\u0131k\u00e7a \u00e7ok \u00f6nemli ve mesele, AB’deki ve AstraZeneca’daki dostlar\u0131m\u0131z aras\u0131nda.” demekle yetindi.<\/p>\n
![\"\"](\"https:\/\/by-tv.co.uk\/wp-content\/uploads\/2025\/12\/bytv-reklam-banner.jpg\")
<\/a><\/div>","protected":false},"excerpt":{"rendered":"